CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects
Author
American Diabetes Association
Farxiga®
+3 more
Forxiga®
Onglyza®
Wertheimer AI
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Achieving Glycemic Goals With Addition of Incretin-based Therapies to Insulin in Patients With Type 2 Diabetes Mellitus
Author
ACTOS
American Diabetes Association
+44 more
Arnolds
Barnett
Buse
Bydureon™
Byetta
DeFronzo
Drucker
Drucker
Drug Safety Communication
Ferrannini
Forxiga™
Fox
Fritsche
Garber
Garg
Hamaty
Holman
Holman
Holman
Invokana™
Inzucchi
Johnston
Joseph Tibaldi
Korytkowski
Levin
Levin
Levin
Mathieu
Misbin
Monnier
Peyrot
Ranjit Unnikrishnan
Ratanawongsa
Rodbard
Rosenstock
Stenlof
Strojek
Symlin®
Testa
Triplitt
UK Prospective Diabetes Study (UKPDS) Group
Vaag
Victoza®
Vilsboll
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref